Radiographic and Intravascular (IVUS) Evaluation of Venous Morphology During CCSVI Treatment

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01593891

Acronym

Resrch_Reg_2

Enrollment

Registered

2012-05-08

Start date

2011-08-31

Completion date

2012-09-30

Last updated

2012-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allow Researchers to Sub-classify Valve Morphology in Relation, Forty-eight Hours by Doppler Ultrasound as Well as Clinical, Symptom Improvement., To Determine the Safety and Validity of Venous Angioplasty and, to Treatment Success. This Will be Evidenced by Venous Patency, Valvuloplasty in the Treatment of CCSVI. In Addition, it Will

Keywords

IVUS, CCSVI

Brief summary

Radio graphic and Intravascular (IVUS) Evaluation of Venous Morphology During Chronic Cerebral Spinal Venous Insufficiency Treatment

Detailed description

To determine the safety and validity of venous angioplasty and valvuloplasty in the treatment of CCSVI. In addition, it will allow researchers to sub-classify valve morphology in relation to treatment success. This will be evidenced by venous patency forty-eight hours by Doppler ultrasound as well as clinical symptom improvement.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Ability to comprehend the nature of the study, including the risks and benefits and execute an informed consent * Males or Females between the ages of 20 and 60 years of age. * Voluntary agreement to participate in the study: Radiographic and Intravascular (IVUS) Evaluation of Venous Morphology During CCSVI Treatment.

Exclusion criteria

* Any implantable/metallic objects that prevents subject from having a magnetic resonance imaging (MRI/MRV) study. * History of uncontrolled hypertension * Previous CCSVI treatment * Presence of hypercoagulable state * Special Populations. Special groups include, but are not limited to children, prisoners, pregnant women, fetuses, and cognitively impaired individuals who are unable to provide informed consent.

Countries

United States

Outcome results